查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765127

全球非血管支架市场

Non-Vascular Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球非血管支架市场规模将达到 22 亿美元

全球非血管支架市场规模预计在2024年为16亿美元，预计到2030年将达到22亿美元，2024年至2030年的复合年增长率为5.1%。泌尿系统支架是本报告分析的细分市场之一，预计其复合年增长率为5.1%，到分析期结束时将达到11亿美元。胃肠道支架市场在分析期间内的复合年增长率预计为5.3%。

美国市场规模估计为 4.459 亿美元，中国市场预期复合年增长率为 4.9%

美国非血管支架市场规模预计2024年达到4.459亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到3.473亿美元，在2024-2030年的分析期间内，复合年增长率为4.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.8%和4.4%。在欧洲，预计德国市场的复合年增长率为4.8%。

全球非血管支架市场－主要趋势与驱动因素摘要

什么是非血管支架？为什么它们对患者照护至关重要？

非血管支架是用来支撑和维持消化器官系统、泌尿器官系统和呼吸系统等非血管通道畅通的医疗设备。这些支架主要用于治疗因肿瘤、狭窄以及食道、胆管、输尿管和气道等器官的其他阻塞所引起的阻塞。与动脉和静脉中使用的血管支架不同，非血管支架专注于缓解软组织器官的阻塞并维持正常的身体功能，例如呼吸、排尿和消化。非血管支架所使用的材料范围从金属合金到生物分解性的聚合物，可根据患者的具体情况量身定制解决方案。在因癌症导致这些系统阻塞的患者的安宁疗护中，非血管支架的使用正变得越来越重要。

科技进步如何彻底改变非血管支架市场？

非血管支架市场近年来经历了重大创新，尤其是在先进材料和支架设计的发展方面。生物分解性支架（一段时间后可溶解）因其可减少再次手术移除支架的需求而日益普及。此外，药物释放型（缓慢释放药物以防止支架周围组织发炎和增生）也正广泛应用。支架灵活性的提高以及自动扩张型支架的开发使其更易于植入，并降低了手术风险。这些技术进步使阻塞治疗更加精准、创伤更小，从而改善了患者的治疗效果并缩短了康復时间。随着微创手术的日益普及，非血管支架越来越多地被用作各种疾病的解决方案，尤其适用于那些不适合接受创伤性手术的患者。

人口和医疗保健趋势如何影响非血管支架市场？

癌症、胃肠道疾病和慢性阻塞性肺病(COPD) 等疾病的盛行率上升是推动非血管支架需求的主要因素。全球人口老化导致胆道、泌尿系统和呼吸道阻塞疾病的盛行率上升。这些人口变化持续推动着安宁疗护和治疗中对支架置入术手术的需求。此外，医疗保健基础设施的进步，特别是新兴市场的进步，正在扩大非血管支架等医疗设备的可近性，增加先前服务不足地区对医疗技术的采用。此外，对患者舒适度和生活品质的日益重视，特别是在肿瘤学领域，正在推动人们越来越依赖非血管支架作为缓解阻塞症状的解决方案。

哪些因素推动了非血管支架市场的成长？

非血管支架市场的成长受到多种因素的推动。自动扩张型支架和药物释放型支架的开发等技术进步改善了治疗效果并减少了併发症，从而导致这些设备的广泛采用。此外，癌症和慢性病的盛行率不断上升，特别是人口老化，也推动了对非血管支架的需求，而非血管支架对于安宁疗护至关重要。此外，微创手术的转变推动了支架取代更具侵入性的手术方法的应用，特别是对于老年和严重患者。新兴市场医疗保健管道的扩大和医疗基础设施投资的增加，为非血管支架市场创造了新的机会。最后，个人化医疗的趋势（客製化支架设计以满足特定患者的需求）进一步推动了市场的成长。

部分

产品类型（泌尿系统支架、胃肠道支架、肺动脉支架、其他产品类型）

受访公司范例

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, Inc.
  • ELLA-CS, sro
  • Glaukos Corporation
  • Hobbs Medical, Inc.
  • Medtronic PLC
  • Synchron, Inc.
  • Taewoong Medical

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP13622

Global Non-Vascular Stents Market to Reach US$2.2 Billion by 2030

The global market for Non-Vascular Stents estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Urology Stents, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Gastrointestinal Stents segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$445.9 Million While China is Forecast to Grow at 4.9% CAGR

The Non-Vascular Stents market in the U.S. is estimated at US$445.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$347.3 Million by the year 2030 trailing a CAGR of 4.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Non-Vascular Stents Market - Key Trends & Drivers Summarized

What Are Non-Vascular Stents and Why Are They Crucial for Patient Care?

Non-vascular stents are medical devices used to support and keep open passageways in non-vascular systems, such as the digestive, urinary, and respiratory tracts. These stents are primarily used to treat obstructions caused by tumors, strictures, or other blockages in organs such as the esophagus, bile ducts, ureters, and airways. Unlike vascular stents, which are used in arteries and veins, non-vascular stents focus on relieving obstructions in soft tissue organs, ensuring normal bodily functions like breathing, urination, or digestion are maintained. Materials used for non-vascular stents range from metal alloys to biodegradable polymers, allowing for tailored solutions based on the patient’s specific condition. The use of non-vascular stents has become increasingly important in palliative care for patients with cancers that lead to blockages in these systems.

How Are Technological Advancements Revolutionizing the Non-Vascular Stents Market?

The non-vascular stents market has seen significant innovation in recent years, particularly with the development of advanced materials and stent designs. Biodegradable stents, which dissolve after a certain period, are gaining traction as they reduce the need for repeat procedures to remove the stent. Additionally, drug-eluting stents, which slowly release medication to prevent tissue inflammation or growth around the stent, are becoming more widely adopted. Improvements in stent flexibility and the development of self-expanding stents have enhanced the ease of implantation and reduced procedural risks. These technological advancements allow for more precise and less invasive treatment of blockages, improving patient outcomes and recovery times. As minimally invasive procedures gain popularity, non-vascular stents are increasingly being deployed as a solution for a range of conditions, particularly in patients who are not ideal candidates for more invasive surgeries.

How Are Demographic and Healthcare Trends Impacting the Non-Vascular Stents Market?

The rising incidence of diseases such as cancer, gastrointestinal disorders, and chronic obstructive pulmonary disease (COPD) is one of the primary drivers of demand for non-vascular stents. With aging populations across the globe, there is an increasing prevalence of conditions that lead to obstructions in the biliary, urinary, and respiratory tracts. This demographic shift is creating sustained demand for stenting procedures as part of both palliative and curative care. Moreover, advancements in healthcare infrastructure, particularly in emerging markets, have expanded access to medical devices such as non-vascular stents, increasing their adoption in regions previously underserved by medical technology. Additionally, the growing emphasis on patient comfort and quality of life, particularly in oncology, has led to a greater reliance on non-vascular stents as a solution to alleviate symptoms caused by obstructions.

What Factors Are Driving Growth in the Non-Vascular Stents Market?

The growth in the non-vascular stents market is driven by several factors. Technological advancements, such as the development of self-expanding and drug-eluting stents, are enhancing treatment outcomes and reducing complications, which in turn is driving wider adoption of these devices. The increasing prevalence of cancer and chronic diseases, particularly in aging populations, is also fueling demand for non-vascular stents as an essential part of palliative care. Furthermore, the shift toward minimally invasive procedures is driving the adoption of stents over more invasive surgical options, particularly for elderly patients or those with severe conditions. Expanding healthcare access in emerging markets, combined with growing investments in medical infrastructure, is opening up new opportunities for the non-vascular stents market. Finally, the trend toward personalized medicine, with customized stent designs for specific patient needs, is further bolstering market growth.

SCOPE OF STUDY:

The report analyzes the Non-Vascular Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Urology Stents, Gastrointestinal Stents, Pulmonary Stents, Other Product Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, Inc.
  • ELLA-CS, s.r.o.
  • Glaukos Corporation
  • Hobbs Medical, Inc.
  • Medtronic PLC
  • Synchron, Inc.
  • Taewoong Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Non-Vascular Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Gastrointestinal Disorders Drives Demand for Non-Vascular Stents in Endoscopic Procedures
    • Increasing Adoption of Urological Stents Expands Market for Non-Vascular Solutions in Kidney and Urinary Tract Treatments
    • Growing Use of Biliary Stents Fuels Market Growth in the Treatment of Bile Duct Obstructions and Gallstones
    • Technological Advancements in Self-Expanding Stents Propel Growth in Non-Vascular Applications for Digestive Health
    • Rising Demand for Non-Vascular Stents in Colorectal Cancer Treatment Expands Market for Minimally Invasive Oncology Solutions
    • Increasing Use of Pancreatic Stents Strengthens Market for Non-Vascular Stents in Gastrointestinal Surgeries
    • Emerging Focus on Non-Vascular Stents for Airway Management Fuels Growth in Respiratory and Pulmonary Applications
    • Rising Adoption of Non-Vascular Stents in Palliative Care Expands Opportunities for End-of-Life Interventions
    • Growing Demand for Non-Vascular Stents in Pediatric Patients Expands Market for Specialized Stenting Solutions
    • Technological Innovations in Biodegradable and Drug-Eluting Non-Vascular Stents Propel Growth in Long-Term Treatment Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Non-Vascular Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Non-Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Non-Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Non-Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Urology Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Urology Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Urology Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Gastrointestinal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Gastrointestinal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Gastrointestinal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Canada 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Japan 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • CHINA
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: China 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Non-Vascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Non-Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: France 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Germany 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Italy 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: UK 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 53: Rest of World Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of World Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of World 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030

IV. COMPETITION